Switch to Darunavir/r + Maraviroc QD in Patients With R5 Tropism by Viral DNA Genotyping With Suppressed Viremia (GUSTA): a Multicenter, Open-label, Randomized Controlled Trial
Phase of Trial: Phase IV
Latest Information Update: 26 Oct 2016
At a glance
- Drugs Darunavir (Primary) ; Maraviroc (Primary) ; Antiretrovirals; Ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms GUSTA
- 07 Jun 2017 Biomarkers information updated
- 05 Feb 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 03 Feb 2015 Planned End Date changed from 1 May 2016 to 1 May 2017, as reported by ClinicalTrials.gov.